UNRAVEL BIOSCIENCES RECEIVES GRANT TO SUPPORT NEURODEGENERATIVE TARGET DISCOVERY

Award from MGH CCXDP advances effort to identify new treatments for X-linked dystonia Parkinsonism (XDP) BOSTON, March 29, 2023 /PRNewswire/ -- Unravel Biosciences, Inc., ("Unravel"), a therapeutics company that leverages a machine-learning model of human health to advance drugs for...